Innovating Works

GBS

A stranger
SENATOR: Staff Exchange for Novel applications in 19f magnetic resonance imaging GOOD BIOMARKER SCIENCES BV participó en un H2020: H2020-MSCA-RISE-2019 Magnetic resonance imaging (MRI) is a leading clinical diagnostic technique, which is able to provide whole body imaging, and when individua...
2019-10-21 - 2024-04-30 | financed
PAVE: A nanovaccine Approach for the treatment of Pancreatic Cancer GOOD BIOMARKER SCIENCES BV participó en un H2020: H2020-MSCA-ITN-2019 A Nanovaccine Approach For The Treatment of Pancreatic Cancer By Multicomponent Immuno-Modulation: Pancreatic ductal adenocarcinoma (PDAC) i...
2019-09-12 - 2024-03-31 | financed
ThromboSLE: Accurate assessment of thrombosis risk in systemic lupus erythematosus GOOD BIOMARKER SCIENCES BV processed a H2020: H2020-SMEInst-2016-2017 Patients with systemic lupus erythematosus (SLE) are at high risk for thrombosis, a major and life-threatening complication of SLE and one o...
2018-02-09 - 2018-08-31 | financed
ACTION: Aggression in Children Unraveling gene environment interplay to inform Treatment and InterventiON s... GOOD BIOMARKER SCIENCES BV participó en un FP7: Aggression inflicts a huge personal, psychological and financial burden on affected individuals, their relatives, and society at large. Desp...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.